Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02).
about
Targeting breast cancer outcomes-what about the primary relatives?The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.No strong evidence for increased risk of breast cancer 8-26 years after multiple mammograms in their 30s in females at moderate and high familial risk.The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.Communication Between Breast Cancer Patients Who Received Inconclusive Genetic Test Results and Their Daughters and Sisters Years After Testing.
P2860
Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Mammographic surveillance in w ...... risk of breast cancer (FH02).
@en
type
label
Mammographic surveillance in w ...... risk of breast cancer (FH02).
@en
prefLabel
Mammographic surveillance in w ...... risk of breast cancer (FH02).
@en
P2093
P2860
P50
P1433
P1476
Mammographic surveillance in w ...... l risk of breast cancer (FH02)
@en
P2093
D M Sibbering
FH02 study group
M G Wallis
P2860
P2888
P356
10.1007/S10689-013-9661-8
P577
2014-03-01T00:00:00Z